[HTML][HTML] Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

MF Muers, RJ Stephens, P Fisher, L Darlison… - The Lancet, 2008 - thelancet.com
Background Malignant pleural mesothelioma is almost always fatal, and few treatment
options are available. Although active symptom control (ASC) has been recommended for …

Reproducibility of walking test results in chronic obstructive airways disease.

AJ Knox, JF Morrison, MF Muers - Thorax, 1988 - thorax.bmj.com
Thirty six patients with chronic airflow obstruction were studied to examine (1) the
reproducibility and order effect of repeated walking tests when performed over consecutive …

Population based epidemiology and prognosis of mesothelioma in Leeds, UK

A Chapman, S Mulrennan, B Ladd, MF Muers - Thorax, 2008 - thorax.bmj.com
Introduction: Malignant mesothelioma is a fatal neoplasm, which is rapidly increasing in
incidence throughout Western Europe. To date there have been no studies reporting on the …

Acute hydrocortisone myopathy in acute severe asthma.

AJ Knox, BH Mascie-Taylor, MF Muers - Thorax, 1986 - ncbi.nlm.nih.gov
Discussion There are only two previous single case reports of acute hydrocortisone
myopathy occuring in acute severe asthma.'2 There are similarities between our case and …

Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer

JM Allan, LJ Hardie, JA Briggs… - … journal of cancer, 2001 - Wiley Online Library
Evidence suggests that the majority of lung cancer patients have tumour‐derived genetic
alterations in circulating plasma DNA, and that this may be developed as a diagnostic tool …

The challenge of improving the delivery of lung cancer care

MF Muers, WF Holmes, C Littlewood - Thorax, 1999 - thorax.bmj.com
Lung cancer has a poor prognosis. It is reasonably common in general practice, needs good
palliative care, and requires co-operation between several health care teams to be …

Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical …

DJ Girling, MF Muers, W Qian, D Lobban - Seminars in oncology, 2002 - Elsevier
Malignant mesothelioma is almost invariably fatal. The incidence of the disease is rising
rapidly in many countries, and there is no generally accepted standard treatment for patients …

[BOOK][B] Supportive care in respiratory disease

S Ahmedzai, MF Muers - 2005 - books.google.com
Respiratory symptoms such as breathlessness and cough are common in patients with
advancing and incurable disease. For example, cancer, chronic cardiac and pulmonary …

Effect of regular use of high-dose nebulized β2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation

J Congleton, MF Muers - Chest, 1998 - Elsevier
Study objectives A proportion of patients with chronic airflow limitation (CAL) have a raised
resting energy expenditure (REE). The mechanism underlying this is not known. The …

Quitting smoking and lungs

MF Muers - The Lancet, 1999 - thelancet.com
Unlike Mark Twain, most smokers find quitting difficult. A heavy smoker who stops once,
never to start again, is rare. The average number of attempts for those who eventually …